News & events

CE Mark approval for FMX314

Fortimedix Surgical today announced it has received CE Mark approval for FMX314, the world’s first single-port surgery solution that is compatible with a standard 15mm trocar for use in minimally invasive abdominal laparoscopic surgery. FMX314 addresses unmet needs in laparoscopic surgery by providing a platform solution that is small, simple and secure.
Read the full article

510(k) clearance for FMX314

Fortimedix Surgical today announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for FMX314, an innovative single-port platform for use in minimally invasive abdominal laparoscopic surgery.
Read the full article

Gynecology cases performed successfully with FMX314

Following successful use of FMX314 in general surgery, the innovative platform for single-port laparoscopy has now been employed in several gynecologic procedures including tubal sterilization and ovarian cyst treatment with positive results, confirming the versatility of the platform for other surgical applications.
Read the full article

Note: FMX314 is the engineering code name for symphonX™ used during the pre-commercial phase.

For media inquiries, please contact Marc van de Graaf via +1(858) 414 4989 or via our media(at)fortimedix.com

Copyright © Fortimedix Surgical 2019. All rights reserved.

 

Stay updated about the latest developments and innovations from Fortimedix Surgical - subscribe to our newsletter via our subscription form.

By using our website you consent to all cookies in accordance with our Cookie Policy.